iDD - About the company
iDD is a seed company based in Gurugram (India), founded in 2009 by Yogesh Sharma, Patrick Benson, D T Arasu, Ravi Rangasami and Karkavel Jegadesan. It operates as a Provider of a cloud-based clinical drug development and clinical trial management software and services. iDD has raised $2.22M in funding from Millennium Medicare and Ebizzbox Online, with a current valuation of ₹*****. The company has 303 active competitors, including 54 funded and 42 that have exited. Its top competitors include companies like Medidata, Verily and IQVIA.
Company Details
Provider of a cloud-based clinical drug development and clinical trial management software and services. The company has developed clinical trial amendment products as the iSmart that allows the users to remotely control, conduct, and collect data for drug development. The product is a wearable biosensor with technology that shows biometric data on the trial conducted on-site for analyzing the data on a real-time basis. The iPET is another tool developed by the company for patient enrollment and recruitment process.
- Website
- www.iddresearch.com/
- Social
- Email ID
- *****@iddresearch.com
- Phone Number
- +1 **********
- Registered Address
- No.153, 6th street, Krishna Nagar, Tambaram West, chennai, Tamil Nadu, India, 600045
Key Metrics
Founded Year
2009
Location
Gurugram, India
Stage
Seed
Total Funding
$2.22M in 3 rounds
Latest Funding Round
Post Money Valuation
₹***** as on May 07, 2025
Investors
Ranked
34th among 303 active competitors
Annual Revenue
₹10 - ₹50 Cr as on Mar 31, 2025
Employee Count
100 as on Jun 30, 2026
Legal entities associated with iDD
iDD is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
I5 CLINICAL RESEARCH PRIVATE LIMITED CIN: U73100TN2009PTC073642 , India, Active | Nov 23, 2009 | 0 - ₹10 Cr (As on Mar 31, 2025) | - | |
MEDLIX HEALTH SOLUTIONS PRIVATE LIMITED CIN: U74999TN2018FTC124442 , India, Active | Sep 07, 2018 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | 69 (As on Feb 01, 2026) |
Sign up to download iDD's company profile
iDD's funding and investors
iDD has raised a total funding of $2.22M over 3 rounds. Its first funding round was on Apr 29, 2023. Its latest funding round was a Seed round on Dec 02, 2024 for $*****. 8 investors participated in its latest round. iDD has 11 institutional investors and 37 angel investors.
Here is the list of recent funding rounds of iDD:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 02, 2024 | 9749134 | Seed | 3317822 | 3807504 | 6688592 | 4234438 |
Mar 29, 2024 | 6336297 | Seed | 4780111 | 3508401 | 2201005 | |
Apr 29, 2023 | 9181707 | Angel | 2370567 | 3170787 | 2313081 | 1242349 |
Access funding benchmarks and valuations. Sign up today!View details of iDD's funding rounds and investors
iDD's founders and board of directors
Founder? Claim ProfileThe founders of iDD are Yogesh Sharma, Patrick Benson, D T Arasu, Ravi Rangasami and Karkavel Jegadesan.
Here are the details of iDD's key team members:
- Yogesh Sharma: Co-Founder of iDD and founder of 4 other companies, including Medlix Hospitals, Cureos and LabForSure. They serve on the boards of 2 companies.Contact Info: 2 email addresses and 1 phone number
- Patrick Benson: Co-Founder of iDD. They serve on the board of 1 company.
- D T Arasu: Co-Founder & Managing Director of iDD. Contact Info: 1 email address
- Ravi Rangasami: Co-Founder & Managing Director of iDD.
- Karkavel Jegadesan: Co-Founder & CTO of iDD.
View details of iDD's Founder profiles and Board Members
iDD's employee count trend
iDD has 100 employees as of Jun 26. Here is iDD's employee count trend over the years:
Uncover iDD's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
iDD's Competitors and alternates
Top competitors of iDD include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of iDD, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Medidata 1999, New York City (United States), Acquired | AI-based clinical trial management software for researchers | $41.5M | 86/100 | |
2nd |  Verily 2015, Dallas (United States), Series D | A data platform and technology company purpose-built to power AI-enabled precision health | $2.8B | 82/100 | |
3rd |  IQVIA 1982, Durham (United States), Public | Provider of clinical research and commercialization solutions for healthcare | $1.74M | 80/100 | |
4th |  Tempus 2015, Chicago (United States), Public | Developer of genomic testing and artificial intelligence tools for medicine | $1.05B | 78/100 | |
5th |  Signant Health 2000, Plymouth Meeting (United States), Acquired | Provider of a software solution for clinical trial management | $3.4M | 72/100 | |
6th |  Science 37 2014, Los Angeles (United States), Acquired | Provider of a suite solution for clinical trials for researchers | $106M | 70/100 | |
7th | Viz.ai 2016, San Francisco (United States), Series D | Developer of an AI-powered platform for care coordination and disease detection | $252M | 69/100 | |
8th |  Massive Bio 2014, New York City (United States), Series B | Provider of AI-based clinical trial management tool | $15.6M | 67/100 | |
9th |  TriNetX 2013, Cambridge (United States), Acquired | Provider of clinical trial management software for researchers and professionals | $102M | 66/100 | |
10th | _1556172390155.png?devicePixelRatio=2&height=30&width=30){kind=logo} BrightInsight 2017, San Jose (United States), Series C | Provider of digital health solutions for clinical trials | $179M | 64/100 | |
34th | Provider of a cloud-based clinical drug development and clinical trial management software and services | $2.22M | 48/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on iDD's competitors? Click here to see the top ones
iDD's Latest cap tables and shareholding
Founders (largest shareholder) own 66.69%, Funds own 2.47%, Enterprises own 5.11% and Angels own 15.05%. The net worth of iDD's founders is INR 134Cr as of May 07, 2025.
Shareholders Name | Post Round Holding % | Net worth | Cumulative Investment | Realised Returns | Unrealised Returns | Return Multiple |
|---|---|---|---|---|---|---|
Founder | 66.69% | 134Cr | 8490972 | 4455206 | 1607942 | 1979472 |
2622562 | 4744668 | 4374163 | 9985684 | 6790131 | 9526829 | |
9987858 | 8210344 | 1461521 | 4920099 | 2832768 | 6565110 | |
Fund | 2.47% | 4.99Cr | 95 | 44 | 46 | 45 |
Enterprise | 5.11% | 10.3Cr | 59800 | 48230 | 51424 | 65115 |
Angel | 15.05% | 30.4Cr | 7349618 | 4475871 | 3792954 | 7006488 |
3 | 1 | 8 | 3 | 4 | 3 | |
0 | 0 | 0 | 0 | 0 | 0 | |
Other People | 9.24% | 18.6Cr | 2498555 | 5725364 | 5943962 | 3139279 |
ESOP Pool | 1.43% | 2.89Cr | 2 | 5 | 5 | 6 |
Total | 100.00% | 202Cr | 7206119 | 4581524 | 2968670 | 6018888 |
To unlock detailed Cap Table of iDD Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of iDD's Shareholding
iDD's Investments and acquisitions
iDD has made no investments or acquisitions yet.
Reports related to iDD
Here is the latest report on iDD's geography:
Are you a Founder ?
FAQs about iDD
Explore our recently published companies
